mercoledì, 12 marzo 2025

Notizie AIOM – anno XVI

28 Ottobre 2024

ICTUS, MENO DEL 30% DELLE PERSONE RICONOSCE I SEGNI

In Italia l’ictus colpisce ogni anno 120mila persone, ma meno del 30% degli italiani è in grado di riconoscerne i segni per intervenire rapidamente. Per contribuire alla sensibilizzazione riguardo la prevenzione e al miglioramento di presa in carico e cura dei pazienti, ...
Leggi tutto

18 Dicembre 2018

FDA Pipeline: New Priority Reviews, Designations, and Clearances, Plus Statements on Genetic Testing and Class Labeling

December 11, 2018 - The FDA accepted a supplemental biologics license application (sBLA) and granted Priority Review for atezolizumab in combination with carboplatin and etoposide for the first-line treatment of patients with extensive-stage small cell lung cancer (SCLC). ...
Leggi tutto

18 Dicembre 2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practice

December 12, 2018 - Ensuring the safety of our nation’s drug supply is a cornerstone of our consumer protection mission. Overseeing the quality and safety of pharmaceutical manufacturing is key to these efforts. With the emergence of new markets, supply chains are ...
Leggi tutto

18 Dicembre 2018

Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2

Gemcitabine plus nanoparticle albumin-bound (NAB) paclitaxel (GA) significantly improved survival compared with gemcitabine alone in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) and a Karnofsky performance status (PS) of 70% or greater. Because of the ...
Leggi tutto

17 Dicembre 2018

EU Panel Backs Brentuximab Vedotin for Frontline CD30+ Hodgkin Lymphoma

December 14, 2018 - The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of brentuximab vedotin for use in combination with chemotherapy as a frontline treatment for adult patients with CD30+ stage IV Hodgkin ...
Leggi tutto

17 Dicembre 2018

Scheda informativa condivisa da ISS, PMA, AIMAC e AIOM

Suggerimenti semplici su come preservare la fertilità prima dei trattamenti antitumorali, cofirmati da Istituto Superiore di Sanità (ISS), Registro Nazionale di Procreazione Medicalmente Assistita (PMA), Associazione Italiana Malati di Cancro, parenti e amici ...
Leggi tutto

17 Dicembre 2018

Dal Soroptimist International Club Genova a favore delle ragazze STEM

Il Premio, del valore di 2.000 Euro, sarà attribuito ad una Tesi di Laurea Magistrale in campo Emato-Oncologico, discussa da una studentessa dell’Università degli Studi di Genova negli anni accademici 2016-17 o 2017-18, in una delle seguenti discipline: ...
Leggi tutto

17 Dicembre 2018

The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer

The aim of our study was to investigate whether an inflammation-based prognostic score, the prognostic nutritional index (PNI), was associated with clinical characteristics and prognosis in patients with high-grade serous ovarian cancer (HGSC). We retrospectively investigated ...
Leggi tutto

17 Dicembre 2018

Medical resource utilization of abiraterone acetate plus prednisone added to androgen deprivation therapy in metastatic castration-naive prostate cancer: Results from LATITUDE

Abiraterone acetate plus prednisone (AA+P), when added to androgen deprivation therapy (ADT), demonstrated significant improvements in overall survival and disease progression over dual placebos added to ADT in the LATITUDE clinical trial (NCT01715285). The objective of ...
Leggi tutto

17 Dicembre 2018

10 dicembre 2018 – Dose Flat Pembrolizumab (Merck Sharp & Dohme)